Diagnostics

Up to 14.9 million Europeans suffer from chronic wounds. A new industry white paper details the staggering cost and provides a roadmap for urgent policy reform.

A new, imageable liver cancer therapy is one step closer to patients, thanks to a strategic partnership securing a vital US-based medical isotope supply.

Amid rising rabies deaths in Sarawak, an international summit aims to unite Asia in the fight against the fatal disease. Can collaboration turn the tide?

A shocking new installation reveals a dangerous blind spot: your car isn't protecting you from the sun's harmful rays. Here's what you need to know.

The diagnostics firm posts strong thyroid growth after a strategic shift, but a one-time tax adjustment inflates its impressive 2025 bottom line.

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

Agena Bioscience's new test helps labs align with updated ACMG recommendations for cystic fibrosis, aiming for more equitable and efficient carrier screening.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

After a major capital overhaul, PAVmed pivots to growth, advancing cancer diagnostics, remote monitoring, and a relaunched device portfolio.

Over 3.5 million Africans suffer from psoriasis with little support. A historic forum in Nairobi aims to shatter the silence and forge a new path for care.

A Denver clinic now offers Therapeutic Plasma Exchange for anti-aging. But does the science back up the high-cost promise of turning back the clock?

A landmark partnership is scaling a 'one-drug, many-diseases' therapy, revealing how logistics, not just labs, are key to the future of medicine.

A gene expression test is changing melanoma care by providing risk data beyond traditional staging, enabling more tailored treatment for patients.

A major investment aims to develop biomarkers for TAND, the neuropsychiatric challenges affecting most with TSC, offering new hope for families.

Biocon names 30-year veteran Shreehas Tambe as its new CEO, consolidating its biosimilar and generics arms to create a global biopharma powerhouse.

A French biopharma's leap in synthetic lipid production de-risks its lead drug, eyes a vast sepsis market, and creates new commercial avenues.

INNOVATE Corp. reports a 62% Q4 revenue surge, but a 'going concern' warning and looming debt have forced the company to explore selling key assets.

Patterson Companies appoints Gregg Kunes as Chief Digital Officer, signaling a major tech push to reshape the dental and animal health supply chains.

A Texas clinic is combining brain health therapy, facial rejuvenation, and body sculpting in a novel, 'whole person' approach to wellness and recovery.